Scleral Lenses Market

Rising number of eye disorders and the increasing geriatric population are driving the market growth

Market CAGR for Scleral Lenses is driven by the rising number of eye disorders and the increasing geriatric population. Scleral lenses are utilized for correcting various vision defects such as myopia, irregular cornea, ocular surface disease, refractive errors, hyperopia, astigmatism, and presbyopia. The anticipated rise in the prevalence of these conditions is expected to propel the scleral lens market in the forecast period. According to the World Health Organization, myopia has the highest prevalence in East Asian countries like Japan, South Korea, and Singapore.

A 2019 article from the National Center for Biotechnology Information predicts that by 2050, myopia and high myopia are projected to impact approximately 4,949 million and 925 million people  ly, respectively. The increasing instances of myopia, coupled with growing expenditure on ophthalmic products, including scleral lenses as corrective measures for refractive errors, are anticipated to fuel the growth of the scleral lenses market.

With a substantial population base, developing nations  ly, including Mexico, BRIC nations (Brazil, Russia, India, China), and South Africa, present promising growth opportunities for manufacturers of contact lenses. China and India, having the highest populations, generate a significant demand for scleral lenses due to the increasing prevalence of eye defects attributed to the growing geriatric population in these regions. The geriatric population is expected to surge from 548 million in 2019 to nearly 1.3 billion by 2050, contributing to the prevalence of age-related eye diseases.

The Global Scleral Lenses Market Industry is projected to experience substantial growth over the next decade. With an estimated market value of 0.34 USD Billion in 2024, it is anticipated to reach 0.7 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 6.85% from 2025 to 2035, reflecting the increasing adoption of scleral lenses across various demographics. The market dynamics indicate a robust demand for innovative and effective vision correction solutions, positioning scleral lenses as a key player in the optical industry.

The aging population globally is a crucial driver for the Global Scleral Lenses Market Industry. As individuals age, they often experience various eye-related issues, including presbyopia and other refractive errors. Scleral lenses offer a viable solution for older adults who may struggle with traditional contact lenses or glasses. The increasing number of elderly individuals is expected to contribute to the market's expansion, as more seniors seek effective vision correction options. This demographic shift is likely to sustain a compound annual growth rate of 6.85% from 2025 to 2035.

Scleral lenses are recognized for their ability to provide enhanced comfort and superior vision quality compared to traditional lenses. This characteristic is particularly appealing to individuals with irregular corneas or other complex eye conditions. The Global Scleral Lenses Market Industry benefits from this trend, as patients increasingly seek solutions that offer both comfort and clarity. As more individuals experience the advantages of scleral lenses, the market is expected to expand, driven by the demand for high-quality vision correction solutions.

The Global Scleral Lenses Market Industry is witnessing growth due to the rising incidence of eye disorders such as keratoconus and severe dry eye syndrome. These conditions often necessitate specialized vision correction solutions, with scleral lenses emerging as a preferred option. The demand for scleral lenses is expected to rise as more individuals seek effective treatments for these debilitating conditions. In 2024, the market is projected to reach 0.34 USD Billion, reflecting a growing awareness and acceptance of scleral lenses among both patients and healthcare providers.

Innovations in lens design and manufacturing processes are propelling the Global Scleral Lenses Market Industry forward. Advances in materials and digital manufacturing techniques have led to the development of more comfortable, durable, and customizable scleral lenses. These improvements not only enhance patient satisfaction but also expand the range of conditions that can be effectively treated with scleral lenses. As a result, the market is likely to experience significant growth, with projections indicating a rise to 0.7 USD Billion by 2035, driven by these technological enhancements.

There is a notable increase in awareness and acceptance of specialty lenses, including scleral lenses, within the Global Scleral Lenses Market Industry. Educational initiatives by healthcare professionals and organizations have played a pivotal role in informing patients about the benefits of scleral lenses. This growing awareness is likely to lead to higher adoption rates, as patients become more informed about their options for vision correction. Consequently, the market is poised for growth, with an anticipated increase in demand for scleral lenses in the coming years.

By region, the study provides the market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The anticipated expansion of the Scleral Lenses market in North America can be attributed to several key factors. The market in the region is experiencing growth due to the increased focus on research and development, strategic partnerships, and the introduction of new products by key industry players. For Instance, in February 2021, Johnson & Johnson Vision, a division of Johnson & Johnson Services, unveiled the TECNIS Toric II 1-Piece Intraocular Lens in the United States.

Additionally, Johnson & Johnson made a significant investment of approximately USD 4 billion in the acquisition of Abbott Medical Optics, encompassing ophthalmic products related to cataract surgery, laser refractive surgery, and consumer eye health. These product lines have been integrated with the ACUVUE Brand Contact Lenses business, operating collectively under the brand name Johnson & Johnson Vision (J&J Vision). This acquisition has positioned Johnson & Johnson competitively in cataract surgery, aligning with Abbott Medical Optics' expertise. Consequently, these strategic initiatives are driving market growth in the region.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: Scleral Lenses Market Share By Region 2023 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe's Scleral Lenses Market accounts for the second-largest market share as In Western Europe, the number of individuals experiencing moderate to severe vision loss due to refractive disorders surpassed 8.5 million. Contrastingly, Eastern Europe exhibits the highest prevalence of eye problems across the continent. In 2020, nearly 7.5 percent of the population in this region faced near vision impairment, while 3.6 percent encountered moderate to severe vision loss, and two percent had mild vision afflictions.

The growth of the scleral lenses market in Europe is influenced by the increasing awareness among eye care practitioners and patients regarding the advantages of these lenses. Educational initiatives and outreach programs conducted by eye care professionals and manufacturers contribute significantly to enhancing the understanding of how scleral lenses can effectively address specific eye conditions. Further, the German Scleral Lenses Market held the largest market share, and the UK Scleral Lenses Market was the fastest-growing market in the European region

The Asia-Pacific Scleral Lenses Market is expected to grow at the fastest CAGR from 2025 to 2034. India is anticipated to experience accelerated growth in the field of scleral lenses, driven by advancements in medical technology, government initiatives supporting eye problem treatments, and a substantial patient base. The expanding population and rising incidence of eye diseases in India are expected to contribute to the increased adoption of scleral lenses in the region.

According to the National Blindness and Visual Impairment Survey conducted by the Union Ministry of Health and Family Welfare between 2015 and 2019, the prevalence of blindness in India stands at 0.36 percent, affecting approximately 6.2 million people. The survey also indicates a prevalence of 1.06 percent for moderate to severe visual impairment, impacting around 55 million individuals. Notably, the prevalence of blindness is 1.37 times higher in rural areas compared to urban areas, while moderate to severe visual impairment is 1.22 times more prevalent.

Additionally, in individuals aged 50 and above, the prevalence of blindness is 1.43 percent, with 4.06 percent experiencing moderate to severe visual impairment. This increased prevalence has led to an enhanced availability of scleral lens products in India, with expectations of optimal growth in the forecast period. Moreover, China’s Scleral Lenses Market held the largest market share, and the Indian Scleral Lenses Market was the fastest-growing market in the Asia-Pacific region.

Leading market players are investing heavily in research and development to expand their product lines, which will help the Scleral Lenses market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their   footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Scleral Lenses industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the   Scleral Lenses industry to benefit clients and increase the market sector. In recent years, the Scleral Lenses industry has offered some of the most significant advantages to individuals with corneal irregularities, ocular surface diseases, and other vision-related challenges.

Major players in the Scleral Lenses Market, including ABB Optical Group, Bausch Health Companies Inc., Visionary Optics, Essilor, Art Optical Contact Lens, Inc., CooperVision, BostonSight, AccuLens, Inc., Tru-Form Optics, SynergEyes, Valley Contax, Capricornia and Menicon Co., Ltd are attempting to increase market demand by investing in research and development operations.

Essilor is a company specializing in ophthalmic optics, engaged in the design, manufacturing, and marketing of a diverse array of products aimed at correcting vision, safeguarding eyes, and maintaining visual health. Their product range encompasses progressive, single vision, anti-fog, anti-reflective, polarized, sun, and photochromic lenses, along with reading glasses, lenses tailored for screen use, as well as various optical accessories such as lamps, filters, magnifiers, and electronic visual aids. The company also focuses on the development and marketing of equipment, instruments, and services intended for eyecare professionals.

Among its prominent brands are Varilux, Crizal, Transitions, Eyezen, Xperio, Foster Grant, Bolon, and Costa. As an example of its performance, EssilorLuxottica reported a 13.4% decrease in sales in the Lenses and Optical Instruments segment in 2020 compared to 2019.

BostonSight is at the forefront of advancing the treatment of diseased or damaged corneas and addressing dry eyes. Since its establishment in 1992 in Needham, MA, the Center of Excellence has been instrumental in saving the sight of numerous individuals grappling with ocular surface disease and irregular corneas. The facility encompasses a clinic, research center, cutting-edge manufacturing lab, and a support center for patients and their families. The PROSE® by BostonSight represents a medical treatment employing highly customized scleral lens devices.

These devices are designed to restore both visual and physiological function in patients dealing with ocular surface disease, corneal issues, injuries, or damage. For many individuals, this treatment stands as the sole option to regain vision and alleviate the suffering caused by critical and debilitating eye conditions. Expanding   access to their scleral lens technology, BostonSight SCLERAL® aims to optimize scleral lens fitting, thereby enhancing satisfaction for both patients and practitioners. This ready-to-fit scleral lens option enables practitioners to promptly and effectively assist patients in achieving optimal vision and comfort.